SNARE chaperones of the Sec1/mammalian Unc-18 (SM) family have critical roles in SNAREmediated membrane fusion. Using SNARE and Sly1 mutants, and a new in vitro assay of fusion, we separate and assess proposed mechanisms through which Sly1 augments fusion: (i) opening the closed conformation of the Qa-SNARE Sed5; (ii) close-range tethering of vesicles 5 to target organelles, mediated by the Sly1-specific regulatory loop; and (iii) preferential nucleation of productive trans-SNARE complexes. We show that all three mechanisms are important and operate in parallel, and we present evidence that close-range tethering is particularly important for trans-complex assembly when cis-SNARE assembly is a competing process. In addition, the autoinhibitory N-terminal Habc domain of Sed5 has at least two 10 positive activities: the Habc domain is needed for correct Sed5 localization, and it directly promotes Sly1-dependent fusion. Remarkably, "split Sed5," with the Habc domain present only as a soluble fragment, is functional both in vitro and in vivo.
INTRODUCTION

15
SNARE-mediated membrane fusion is central to secretory cargo transport, exocytosis, and organelle biogenesis and homeostasis (Jahn and Fasshauer, 2012; Ungar and Hughson, 2003) .
Fusion is preceded by tethering, mediated by a diverse group of proteins and usually controlled by small G proteins of the Rab, Arf, or Rho families (Angers and Merz, 2011; Bombardier and Munson, 2015; Pfeffer, 2017; Stenmark, 2012) . Tethering is followed by 20 docking: the assembly of a parallel, tetrahelical trans-SNARE complex ("SNAREpin") that links the two membranes (Hanson et al., 1997; Nichols et al., 1997; Sutton et al., 1998; Weber et al., 1998) . "Zippering" of the incipient trans-SNARE complex does the mechanical work of driving the membranes together to initiate fusion (Zorman et al., 2014) . Each trans-SNARE complex contains four α-helices, one from each of four SNARE subfamilies: R, Qa, Qb, and Qc 25 (Fasshauer et al., 1998) . R-SNAREs often correspond to vesicle-or v-SNAREs, while Qa-SNAREs (also called syntaxins) typically correspond to target membrane, or t-SNAREs. All Qa-SNAREs have in common an N-terminal regulatory "Habc" domain that folds into a trihelical bundle. In some but not all cases the Habc domain can fold back onto the catalytic SNARE domain to form an autoinhibited "closed" conformation (Demircioglu et al., 2014; Dulubova et al., 1999;  Sed5. This in turn allows Sed5 to more readily complex with Qb, Qc, and R-SNAREs (Bos1, Bet1, and Sec22; (Demircioglu et al., 2014; Kosodo et al., 1998) . A limitation of this work is that the SNAREs used were soluble fragments; the roles of Sed5 inhibition and opening were not tested in experiments that assayed membrane fusion. Second, we demonstrated that Sly1 binding to quaternary SNARE complexes in solution slows the kinetics of ATP-dependent 70 disassembly by Sec17 and Sec18 (in mammals, α-SNAP and NSF). Consistent with these findings, in vivo genetic tests revealed that Sec17 overproduction is tolerated in a wild-type genetic background but becomes lethal when Sly1 function is partially compromised (Lobingier et al., 2014) . Third, on the basis of structural homology to Vps33, Baker et al. (2015) proposed that Sly1 can template Qa-and R-SNARE trans-complex formation. Fourth, 75 experiments in a companion manuscript (Duan et al., submitted) demonstrate that Sly1 can promote close-range vesicle tethering through an amphipathic helix, α21, that directly interacts with the vesicle membrane.
All of these mechanisms are plausible, yet no study to date has attempted to assess their functional contributions within a unified experimental framework. Here we begin that 80 effort, combining in vivo genetic tests with a new chemically defined in vitro reconstitution of fusion on the ER-Golgi anterograde pathway. Focusing on Sly1 interactions with the Qa-SNARE Sed5, we demonstrate that multiple mechanisms do indeed contribute to Sly1's fusionpromoting activity and, unexpectedly, that the regulatory Habc domain of the Qa-SNARE Sed5 augments Sly1-stimulated fusion, rather than being solely auto-inhibitory.
RESULTS
Sed5 N-peptide is essential for viability and efficient membrane fusion
The Qa-SNARE Sed5 has four domains: an N-peptide of 21 residues that binds tightly to Sly1; a trihelical Habc domain that is auto-inhibitory; the Qa-SNARE domain; and a C-terminal 90 transmembrane segment (Fig. 1A) . In a previous study, missense mutations that reduced the affinity of Sly1 for the N-peptides of its client Qa-SNAREs (Sed5 and Ufe1) resulted in minimal defects in assays for viability, secretion, and Sly1 localization. These results were interpreted to indicate the functional "irrelevance" of Sly1-Sed5 interactions (Peng and Gallwitz, 2004) . In contrast to these findings, overexpression of a Sly1 cognate N-peptide, or of the Sly1 N-95 peptide binding domain, shattered the Golgi in mammalian cells (Dulubova et al., 2003; Yamaguchi et al., 2002) . To reassess whether the Sed5 N-peptide is functionally important in budding yeast we engineered an allele, sed5∆N, that encodes a Sed5 variant lacking the Npeptide (as defined by the crystal structure PDB 1MQS; Bracher et al., 2002; Fig . 1A) . In a genetic background expressing wild type SLY1, sed5∆N was a recessive lethal allele ( Fig. 1B; 100 Supplementary Fig. S1 ). Thus, the Sed5 N-peptide is essential for viability. These results are buttressed by recent experiments showing that sed5(DFTV), a quadruple missense mutant Sed5-∆N lacks the first 21 aminoacyl residues. B. Viability tests. The sed5-∆N allele was tested using sed5∆ sly1∆ double knockout cells that carry intact copies of both SED5 and SLY1 on a single counterselectable plasmid. Forced ejection of the SED5 SLY1 plasmid by plating onto 5-fluoroorotic acid (5-FOA) resulted in lethality unless both SED5 and SLY1 were supplied in trans. Additional controls are presented in Supplementary Fig. S1 . that impairs Sly1 binding to the Sed5 N-peptide, is also recessive lethal (Gao and Banfield, 2019) .
To test whether the Sed5 N-peptide has a direct role in Sly1-dependent fusion we used 105 a chemically defined assay of fusion driven by ER-Golgi SNAREs (Duan et al., submitted; Zucchi and Zick, 2011) . Briefly, we prepare reconstituted proteoliposomes (RPLs) bearing ER-Golgi SNAREs, with two orthogonal FRET reporter pairs. These reporters simultaneously monitor lipid and content mixing in a single 20 µL reaction. Here, we present content mixing results (the reaction endpoint). Fusion requires the presence of Sly1 and also depends on 3% 110 polyethylene glycol, a molecular crowding agent that mimics the action of tethering factors (Duan et al., submitted; Furukawa and Mima, 2014; Lentz, 2007; Mitchison, 2019; Yu et al., 2015) . Sly1-mediated fusion is further stimulated by the universal SNARE disassembly chaperones Sec17 (α-SNAP), Sec18 (NSF), and Mg 2+ ·ATP (Duan et al., submitted) .
To test the function of the N-peptide we prepared RPLs bearing either wild-type Sed5 115 or Sed5∆N (lacking the first 21 aminoacyl residues), as well as the Qb-and Qc-SNAREs Bos1 and Bet1. These Q-SNARE RPLs were assayed for their ability to fuse with RPLs bearing the R-SNARE Sec22. In reactions containing Sec17, Sec18, and Mg 2+ ·ATP, fusion was rapid and efficient when both 3% PEG and Sly1 were present. However, both the rate and extent of fusion were dramatically reduced when RPLs bearing Sed5∆N were tested. Moreover, high 120 concentrations of Sly1 were required to stimulate fusion of Sed5∆N RPLs. With wild type Sed5 near-maximal fusion was observed at 100 nM Sly1, while with Sed5∆N the rate and extent of fusion were much lower even at 1600 nM Sly1 (compare Figs. 2C and 2D). When PEG(which promotes vesicle tethering) was omitted ( Fig. 2F) , fusion with Sed5∆N was undetectable even when 1600 nM Sly1 was added. We conclude that the Sed5 N-peptide strongly promotes Sly1- RPLs are prepared with encapsulated content mixing FRET pair, and with the membranes doped with an orthogonal FRET pair. B. SNARE topology and soluble factors added in these experiments. C-F. Reactions were set up with RPLs, Sec17, Sec18, Mg2+·ATP, and 3% (C,D) or 0% (E,F) PEG. Q-SNARE liposomes bore either wild-type Sed5 (C,E) or Sed5∆N (D,F). The reactions were incubated for 5 min and fusion was initiated by adding Sly1 as indicated at t = 0. Points show mean ±sem of at least three independent experiments. Gray lines show least-squares fits of a second-order kinetic function.
Sly1 hyperactivity suppresses lethality of sed5∆N and restores fusion
The hyperactive allele SLY1-20 was initially identified as a dominant, single-copy suppressor of loss of Ypt1, the yeast Rab1 homolog (Dascher et al., 1991; Ossig et al., 1991) . Single-copy 130 SLY1-20, or multi-copy wild type SLY1, were subsequently found to suppress deficiencies of a wide variety of proteins that mediate intra-Golgi, ER-Golgi, and Golgi-ER vesicle docking and fusion. In the companion paper (Duan et al., submitted) we show that the mechanism of Sly1-20 hyperactivity involves both release of Sly1 autoinhibition and coupled activation of a latent vesicle tethering activity within the Sly1 auto-inhibitory loop. Somewhat surprisingly, SLY1-20 135 was able to suppress the lethal phenotype of sed5∆N, but only when SLY1-20 was provided on a multiple-copy plasmid (Fig. 3A) . Single-copy SLY1-20, or multiple copy wild-type SLY1, were unable to rescue the growth of sed5∆N mutant cells. Thus, the sed5∆N allele is even more deleterious than the already-lethal ypt1-3 (Rab1-deficient) or uso1 (p115/Uso1 tethering factor-deficient) alleles -both of which are efficiently suppressed by single-copy SLY1-20. The 140 survival of sed5∆N cells containing high-copy SLY1-20 also allowed us to verify that Sed5∆N is present at normal abundance and migrates as expected on SDS-PAGE gels ( Fig. 3B) .
Genetic suppression can occur through direct or indirect mechanisms. Thus, we used the RPL system to test whether suppression of sed5∆N by multicopy SLY1-20 occurs through a direct or indirect mechanism. In the presence of PEG, Sly1-20 at 1600 nM was able to drive 145 fusion of Sed5∆N RPLs to nearly the rates and extents seen with wild type Sed5 RPLs and wild type Sly1 at 100 nM (compare Figs. 3C and D). However, in the absence of PEG (that is, under tethering-deficient conditions), Sly1-20 was unable to drive fusion of RPLs bearing Sed5∆N, even at the highest concentrations tested ( Fig. 3E,F) . Taken together, the fusion results closely mirror the in vivo matrix of genetic interactions among SED5 and SLY1 alleles. When 150 wild-type Sly1 is present, fusion is severely attenuated if the Sed5 N-peptide is deleted, but high concentrations of Sly1-20 can rescue Sed5∆21. The in vitro experiments show that this rescue occurs through direct effects on the fusion machinery. With wild-type Sed5, Sly1-20 at moderate concentrations can compensate for tethering deficiencies either in vitro (0% PEG) or in vivo (e.g., ypt1 or uso1 deficiency). However, consistent with in vitro tethering assays (Duan Fig. 3 . High concentrations of Sly1-20 bypass loss of Sed5 N-peptide or tethering, but not both. A, In vivo lethality of sed5∆N is suppressed by SLY1-20 expressed from a multiple-copy plasmid (pRS425) but not from a single-copy plasmid (pRS415). Growth assays were performed as in Fig. 1 ; a more extensive set of controls is presented in Supplementary Fig. S1 . B, In the presence of high-copy Sly1-20, the abundance of Sed5∆N is similar to that of wild type Sed5. Cell extracts were prepared and analyzed by immunoblotting with anti-Sed5 antiserum. C-F, Reactions were set up with RPLs, Sec17, Sec18, Mg2+·ATP, and 3% (C,D) or 0% (E,F) PEG. Q-SNARE liposomes bore either wild type Sed5 (C,E) or Sed5∆N (D,F). The reactions were incubated for 5 min and fusion was initiated by adding Sly1 or Sly1-20 at t = 0. Points show mean ±sem of at least three independent experiments. Gray lines show least-squares fits of a second-order kinetic function.
Sly1 can stimulate fusion independently of Sed5 opening
Sly1 is reported to open closed Sed5, to allow assembly of SNARE core complexes (Demircioglu et al., 2014) . We hypothesized that Sed5 opening might be only one of multiple mechanisms through which Sly1 stimulates fusion. To test this idea, we prepared RPLs bearing two different Sed5 mutants that cannot adopt a closed conformation (Fig. 4A) .
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Sed5∆Habc lacks the autoinhibitory Habc domain required to form a closed conformation, but still has the N-terminal 21 amino acids which bind Sly1 with high affinity. Sed5∆N-Habc lacks both the N-peptide and the Habc domain.
In vivo, both sed5∆Habc and sed5∆N-Habc confer recessive lethal phenotypes. The lethality of these alleles was not suppressed by expression of SLY1 or SLY1-20, from either 170 single-or multiple-copy vectors (Supplementary Fig. S2A ). Analyses in SED5/sed5 cells indicated that the protein products of the sed5 mutant alleles are indeed synthesized ( Supplementary Fig. S2B ). However, these mutant proteins are mis-localized and ultimately degraded in the lumen of the lysosomal vacuole ( Supplementary Fig. S2C ). The Habc domain therefore contains information essential for correct Sed5 localization and in vivo function. To assess the role of Sed5 autoinhibition in membrane fusion we returned to the in vitro RPL assay system. As before, RPLs bearing wild type Sed5 or Sed5∆N exhibited little or fusion when Sly1 was absent ( Fig. 4 B 
Sly1 can stimulate fusion independently of Sed5 opening and close-range tethering
An auto-inhibitory loop conserved among Sly1 family members harbors a close-range vesicle tethering activity, and this activity is indispensable for the hyperactivity of the Sly1-20 mutant (Duan et al., submitted) . We therefore asked whether Sly1 can stimulate fusion independently of both its close-range tethering function and its ability to open the Sed5 closed conformation.
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Reactions were initiated with RPLs bearing Sed5∆Habc (which cannot adopt a closed conformation), and with wild type Sly1 or Sly1 mutants defective in close-range tethering (Fig.   5A ). The Sly1∆loop mutant lacks the entire Sly1-specific regulatory loop including the amphipathic helix α21, which is required for close-range membrane tethering. When
Sly1∆loop was added to reactions containing Sed5-∆Habc RPLs, an increase in fusion was still 200 observed, indicating that Sly1 must have fusion-stimulating activities beyond Sed5 opening and close-range tethering. This conclusion was buttressed by two additional Sly1 mutants. In the Sly1pα21 protein, five apolar residues within helix α21 are mutated, preventing the loop from binding to membranes. Sly1-pα21 has at least two functional defects: it is constitutively auto-inhibited, 205 and it is defective for close-range tethering (Duan et al., submitted). As expected, Sly1-pα21 stimulated only barely detectable fusion above background (Fig. 5A) . In the compound mutant Sly1-20-pα21, autoinhibition is released (the loop is open), but close-range tethering is still compromised. When added to reactions with Sed5∆Habc RPLs, Sly1-20-pα21 stimulated fusion similarly to Sly1∆loop (Fig. 5A) . When the same panel of Sly1 variants was tested with 210 Sed5∆Habc RPLs under tethering-deficient conditions (Fig. 5B) , only Sly1-20 (constitutively open and presenting helix α21) was able to stimulate substantial fusion. Thus, fusion of Sed5∆Habc RPLs requires a tethering activity which can be provided either by the tetheringhyperactive Sly1-20, or by PEG. We conclude that both Sly1 opening of closed Sed5, and Sly1 close-range tethering activity, contribute to the ability of Sly1 to promote fusion, and that Sly1 215 has one or more additional fusion-promoting activities. In Vps33 and Munc18-1, domain 3a appears to serve as a template for trans-SNARE complex assembly (Baker et al., 2015; Jiao et al., 2018) . The near-inability of the constitutively auto-inhibited mutant Sly1-pα21 to stimulate fusion (Fig. 5A) implies that the additional Sly1 activities involve Sly1 domain 3a, which is occluded when Sly1 is auto-inhibited (Baker et al., 2015; Bracher and Weissenhorn, 220 2002).
Close-range tethering by Sly1 promotes assembly of trans-SNARE complexes
Assembly of cis-SNARE complexes occurs spontaneously and competes with assembly of fusion-active trans-complexes. To test the hypothesis that close-range tethering by Sly1 225 specifically favors trans-SNARE complex assembly, we evaluated the inhibitory activity of the soluble R-SNARE domain of Sec22 (Sec22SN-GFP; Fig. 6 ). Reactions were initiated with RPLs bearing the three Q-SNARES along with Sec22SN-GFP (0, 2 or 20 µM), and wild type or mutant forms of Sly1. The reactions were incubated for 15 min, then R-SNARE RPLs were added and the reactions were incubated for an additional 6 min. To initiate fusion PEG was added (t = 0).
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PEG was added to 4% final rather than 3% (as in previous experiments) in an effort to compensate for the tethering defects of the Sly1-20-α21p and Sly1∆loop mutants. Reactions driven by wild-type Sly1 or hyperactive Sly1-20 were partially inhibited by 2 µM Sec22SN-GFP ( Fig. 6B) , and almost totally inhibited by 20 µM Sec22SN-GFP (Fig. 6C) . In contrast, reactions containing Sly1-20-α21p or Sly1∆loop were almost totally inhibited at both 2 and 20 µM 235 Sec22SN-GFP (Fig. 6B,C) . This indicates that reactions driven by tethering-deficient Sly1 mutants are more sensitive to inhibition by cis-complex assembly. We next tested whether inhibition of fusion by Sec22SN-GFP can be reversed by driving cycles of SNARE complex disassembly, to generate free SNAREs on the RPLs. Reactions were initiated as in Fig. 6A-C , but with Sec17, Sec18, and Mg 2+ ·ATP (Fig. 6D-F) . Reactions containing Sly1 or 240 hyperactive Sly1-20 exhibited efficient fusion in the presence of Sec17/18, even at 20µM Sec22SN-GFP. In contrast, reactions driven by the tethering deficient Sly1 mutants exhibited far less rescue. Similar results were obtained when reactions were run under the same conditions, but with 3% rather than 4% PEG (Supplementary Fig. S3 ). Taken together these experiments support the hypothesis that α21-mediated tethering favors assembly of 245 fusogenic trans-SNARE complexes versus non-fusogenic cis-SNARE complexes, even when the pool of unpaired SNAREs is continuously replenished through cycles of Sec17-and Sec18mediated cis-SNARE complex disassembly.
Fig. 7. Helix α21 promotes Sly1 discrimination between cis-and trans-SNARE complexes.
Reactions were initiated with RPLs bearing SNAREs in the indicated topologies. All reactions contained Sec17, Sec18 (100 nM each), and Mg 2+ ·ATP (1 mM). PEG was added to 4% final rather than 3% to assist the tethering-deficient Sly1 mutants. Fusion was initiated (t = 0) by adding the indicated Sly1 mutants to either 100 nM (A-C) or 1600 nM (D-F). Points show mean ±sem of at least three independent experiments. Gray lines show least-squares fits of a second-order kinetic function.
We wondered whether similar results might be obtained under more physiologically relevant conditions, using wild-type membrane-anchored Sec22 rather than soluble Sec22. We 250 therefore assayed the fusion of 4-SNARE QabcR RPLs with 3-SNARE Qabc RPLs, in the presence of wild type and mutant Sly1 variants (Fig. 7) . Because QabcR RPLs can form quaternary SNARE complexes in cis as well as in trans, they require Sec17/18 for efficient fusion. In this configuration the formation of trans-SNARE complexes and the re-formation of cis-SNARE complexes are competing processes. As above, we ran reactions in the presence of 4% PEG in 255 an effort to compensate for the defects of tethering-deficient Sly1 mutants. Even given the results with soluble Sec22, we were surprised at the clarity of the results: Sly1-20-α21p and Sly1∆loop were almost fusion-inactive when confronted with the QabcR SNARE topology (Fig.   7A) , even when the Sly1 mutants were supplied at 1600 nM ( Fig. 7D) and despite the presence of 4% PEG. These defects are considerably more severe than the defects observed in RPL 260 experiments using the Qabc vs. R-SNARE topology, where QabcR cis-SNARE complexes cannot form during the first round of fusion (e.g., Fig. 6a ; and Duan et al., submitted, Fig. 5B,D) . Two mutants hyperactive for close-range tethering , Sly1-20 and Sly1-T559I (Duan et al., submitted), exhibited activity as strong as or stronger than the wild type.
As Sly1 is recruited to the Qa-SNARE Sed5 through a high-affinity interaction with the Sed5 265 N-peptide, we used the Sed5∆N mutant protein to direct Sly1 primarily to either the QabcR RPLs (Fig. 7B,E) , or to the Qabc RPLs (Fig. 7C,F) . The results show that fusion occurs most rapidly when Sly1 is placed in trans to the R-SNARE, Sec22 (Fig. 7C,F) -the configuration where R-SNARE binding in trans is most likely and where cis QabcR complex assembly is least likely to be stimulated by Sly1. Fusion is slowest when Sly1 is placed in cis to the R-SNARE; 270 under this condition, the tethering-deficient Sly1 mutants are almost totally unable to drive fusion (Fig. 7C,D) . Taken together the experiments in Figs. 6 and 7 demonstrate that the Sly1 close-range tethering activity takes on special importance when Sly1 must selectively catalyze formation of trans-SNARE complexes in competition with formation of inactive cis-SNARE complexes.
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Soluble Sed5 Habc domain promotes Sly1-stimulated fusion in vitro
In our experiments comparing various Sed5 mutants, we were surprised to see that although Sed5∆Habc can catalyze spontaneous Sly1-independent fusion, its ability to support Sly1stimulated fusion was reduced compared to wild type Sed5 (compare Figs. 4B and 4D) . These results suggested that the Sed5 Habc domain, in addition to being autoinhibitory, might have 280 a positive, fusion-promoting activity. To test this hypothesis we asked whether the Sed5 Habc domain, supplied in soluble form, would alter the ability of Sly1 and its cognate SNAREs to drive fusion.
Reactions were initiated with Qabc-SNARE RPLs bearing four different Sed5 variants:
wild-type, Sed5∆N, Sed5∆Habc or Sed5 ∆N-Habc. Each of these reactions was performed in 285 the absence or presence of soluble Sed5 Habc or N-Habc (Fig. 8A-D) . Because Sly1 binds to soluble N-Habc domain with sub-nanomolar affinity (Demircioglu et al., 2014) , Sly1 and soluble Habc or N-Habc were pre-mixed before they being added together to the reaction mixture. The reactions were initiated without PEG and monitored for 6 min. To initiate fusion, PEG was added to 3% (t = 0). To our surprise, both the Habc and N-Habc domains of Sed5 290 stimulated fusion in a dose-dependent manner. Fusion was most efficiently stimulated when the N-peptide was present on the soluble Habc domain (Fig. 8B) , rather than on the membrane-bound Sed5 (Fig. 8C) , and less efficiently stimulated when N-peptides were present on both Sed5 and the soluble N-Habc protein (Fig. 8A) . However, Habc stimulated fusion under every condition tested, even when the N-peptide was absent from both Sed5 and 295 the soluble Habc domain (Fig. 8D) .
Similar results were obtained in reactions lacking (Fig. 8A-D) or containing Sec17 and Sec18 (Fig. 8E-H) . Remarkably, in the presence of Sec17 and Sec18 and at the highest concentration of N-Habc, robust fusion was observed even before PEG was added to the reaction (Fig. 8E,F; red asterisks) . This indicates bypass of the tethering requirement -a 300 phenotype previously observed only with hyperactive Sly1 mutants such as Sly1-20 or at very high concentrations of PEG (Duan et al., submitted) . We conclude that the Sed5 Habc domain augments the efficiency of Sly1-stimulated fusion, that the Habc domain need not be covalently coupled to Sed5. In other words, "split Sed5" can drive fusion. 
Split Sed5 can function in vivo
Next, we tested whether soluble Sed5 Habc or N-Habc domains might suppress the lethal phenotype of cells expressing Sed5 variants lacking the Habc domain ( Fig. 9) . Single-copy dicistronic plamids were constructed bearing sed5∆N-Habc or sed5∆Habc, as well as either Habc 310 or N-Habc. These test plasmids were introduced into sly1∆ sed5∆ strains harboring a counterselectable SLY1 SED5 balancer plasmid. In vitro, we had noted that Qabc RPLs bearing wildtype Sed5 fuse with similar efficiency when either Sly1 or hyperactive Sly1-20 are supplied, but that RPLs bearing Sed5∆Habc are considerably more responsive to Sly1-20 ( Fig. 4) . Thus, we also tested the effects of single-copy or multiple-copy plasmids bearing either SLY1 or SLY1-20. 315 The results show that the Sed5 N-Habc domain can support viability when present solely as a soluble fragment (Figs 9A,B) . However, viability of these "split Sed5" cells requires Sly1 hyperactivity. Only SLY1-20 expressed from a high-copy vector supported robust growth with split Sed5. Single-copy SLY1-20 facilitated very slow growth. Moreover, as in the in vitro assays, rescue was most robust when the N-peptide is on the soluble Habc fragment (Figs9 A,B) . No 320 rescue was observed in cells totally lacking the Sed5 N-peptide ( Fig. 9C) and rescue was only barely detectable when the N-peptide was present solely on the membrane-anchored mutant Sed5 (Fig. 9D) .
Immunoblot analyses of whole cell lysates from cells expressing wild-type Sed5
indicated that the the truncated Sed5 variants and soluble fragments were expressed 325 (Supplementary Fig. S4A) . In cells lacking the SLY1 SED5 balancer plasmid and expressing either Sed5∆N-Habc or Sed5∆Habc, the steady-state level of the soluble N-Habc fragment depended on the gene dosage of SLY1-20, suggesting that the stability of the soluble fragment is controlled by its interaction with Sly1-20 protein (Supplementary Fig. S4B) . Taken together, the in vitro and in vivo results here and in (Gao and Banfield, 2019) indicate that, in 330 addition to being auto-inhibitory, the Sed5 Habc domain has positive functions: it both promotes Sly1-dependent membrane fusion, and regulates Sed5 subcellular localization. Fig. 9 . Soluble Sed5 N-Habc fragment supports viability of cells in the presence of SLY1-20. Cells with the indicated genotypes were constructed as described in the text. These strains were grown in liquid media -His -Leu media to maintain the plasmids. Serial dilutions were then plated to either -His -Leu solid media or to solid media containing 5-FOA, to eject the SLY1 SED5 balancer plasmid. Expression of the membrane-anchored Sed5 variants was driven using the native SED5 promoter and terminator. Expression of the soluble Habc and N-Habc fragments was driven using the strong TPI1 promoter and the CYC1 terminator (TC). Immunoblot analyses of Sed5* expression in these cells are shown in Supplementary Fig. S4 .
DISCUSSION
Our experiments show that Sly1 has multiple distinguishable activities which promote SNARE-335 mediated fusion (Fig. 9) . First, Sed5-bound Sly1 has the intrinsic ability to tether incoming vesicles through the amphipathic helix α21 within the Sly1 regulatory loop (Duan et al., submitted) . Second, Sly1 has the ability to open the closed, auto-inhibited conformation of the Qa-SNARE Sed5 (Demircioglu et al., 2014) . When these activities are experimentally bypassed, Sly1 still promotes fusion (albeit less efficiently) through a third activity that 340 probably involves domain 3a. We infer that the third function is probably the selective and accurate nucleation of trans-SNARE complex assembly. These functions are interlinked.
Defects in the Sly1 close-range tethering function result in dramatically impaired fusion when cis-SNARE and trans-SNARE complex assembly are competing processes, indicating that the tethering function is closely coupled to selective catalysis of trans-SNARE complex assembly.
Although the precise mechanism through which this occurs is not yet clear, structural data are suggestive. If the R-SNARE Sec22 binds to Sly1 in a configuration similar to the binding of the R-SNARE Nyv1 to Vps33 (Baker et al., 2015) , then the open Sly1 loop should tether the incoming vesicle in an orientation optimal for capture of the vesicular R-SNARE. We therefore speculate that the close-range tethering mechanism serves not only to inspect incoming 350 vesicle membranes and to trigger Sly1 activation, but to steer Sly1 into a spatial orientation that maximizes the likelihood of productive R-SNARE binding to domain 3a. When cis-SNARE complexes can form in competition with trans-complexes, tethering-defective Sly1 mutants exhibit profound fusion defects, even when tethering is stimulated by 4% PEG (Figs. 6 and 7) .
At the presynaptic nerve terminal the SM protein UNC-18/Munc18-1 seems to lock its 355 Qa-SNARE, Syntaxin-1A, into a closed conformation. Another protein, UNC-13/Munc13-1 appears to be primarily responsible for opening syntaxin-1A (Richmond et al., 2001; Yang et al., 2015) . However, it is unclear whether proteins homologous or analogous to UNC-13 are required for Qa-SNARE opening during other SNARE-mediated fusion events (Pei et al., 2009) . Like Syntaxin-1A, the ER-Golgi Qa-SNARE Sed5 is normally autoinhibited. In domain lacks a groove that might bind to its SNARE domain, yet the SM protein Vps33 is still essential for fusion (Baker et al., 2015; Dulubova et al., 2001; Lobingier et al., 2014; Rieder and Emr, 1997; Seals et al., 2000) . Thus, clamping the Qa-SNARE in a closed conformation, and opening the closed conformation, are pathway-specific elaborations rather than activities common to all SMs.
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In addition to the above functions Sly1 has additional activities. Sly1 reduces the rate of SNARE complex disassembly by Sec17 and Sec18 (Lobingier et al., 2014) . This is consistent with studies of Vps33 and Munc18-1, showing that these SMs protect assembled trans-SNARE complexes from premature disassembly by Sec17 and Sec18 (Lobingier et al., 2014; Prinslow et al., 2019; Schwartz et al., 2017; Song et al., 2017; Stepien et al., 2019; Xu et al., 2010; Duan et 375 al., submitted). Thus we reiterate our previous suggestions (Lobingier et al., 2014; Schwartz et al., 2017) that SM proteins are, sensu stricto, enzymes.
Like all enzymes, SMs bind substrates (vesicular and target SNARE domains), placing them in a stereoselective orientation that reduces the kinetic barrier to formation of product (the trans-SNARE complex); the SMs then dissociate from the product to engage in additional 380 cycles of catalysis (Jiao et al., 2018; Schwartz et al., 2017) . Also as expected for true enzymes, SMs prevent off-pathway reactions (e.g., assembly of non-cognate SNARE complexes, or of cisrather than trans-complexes). They achieve this increase in specificity through kinetic partitioning within the forward assembly pathway (Hardy and Randall, 1991; Lai et al., 2017; Lambright et al., 1994; Peng and Gallwitz, 2002) , and through kinetic proofreading of incorrect 385 SNARE assemblies, since SMs selectively protect cognate SNARE complexes from premature disassembly by proofreading enzymes, while non-cognate complexes are efficiently disassembled (Choi et al., 2018; Lobingier et al., 2014; Prinslow et al., 2019; Schwartz et al., 2017; Song et al., 2017; Xu et al., 2010) .
We were somewhat surprised to find that Sly1-dependent fusion driven by Sed5∆Habc 390 is slower than fusion driven by wild-type Sed5. Similarly, deletion of the Vam3 Habc domain causes a kinetic defect in homotypic vacuole fusion (Laage and Ungermann, 2001; Lürick et al., 2015; Pieren et al., 2010) ; but see (Wang et al., 2001) . When we added soluble Habc domain to reactions containing Sed5∆Habc RPLs, fusion activity was restored to wild-type or nearly wild-type levels (Fig. 8) . The Habc domain of Sed5 therefore must have a positive function.
395
What could this function be? Pieren et al. (2010) suggested that the Vam3 Habc domain might, through an interaction with Vps33, facilitate a transition from lipid mixing to content mixing. However, we have detected no signals consistent with the hypothesis that the Sed5 Habc domain influences the transition from lipid to content mixing. Experiments from the Zhang laboratory are more suggestive of an underlying mechanism. Using single-molecule force 400 spectroscopy, they probed the formation and stability of template complexes consisting of neuronal SNAREs and the cognate SM Munc18-1. Formation of the SNARE-Munc18-1 template complex was almost an order of magnitude less efficient when Syntaxin lacked its N-terminal regulatory domain (the N-peptide and Habc domain). In a striking parallel to our fusion experiments ( Figs. 8 and 9) , addition of the soluble N-Habc domain rescued template complex 405 formation and increased stability of the template complex by almost an order of magnitude (Jiao et al., 2018) . The underlying structural basis for this stabilization is not yet understood.
MATERIALS & METHODS
Yeast strains, genetic tests, and microscopy. Yeast and E. coli strains are listed in 410 Supplementary Table I . Viability assays were performed as described (Gao and Banfield, 2019).
Proteins. Full length SNAREs were expressed and purified as described in the companion manuscript. Constructs used to express mutant forms of Sed5 are listed in Supplementary   Table 1 . Sed5 mutants bearing transmembrane domains were expressed and purified as for 415 full-length wild type Sed5. Soluble domains of Sed5 were expressed and purified as in the companion manuscript. Sly1 and its mutants were expressed and purified as described (Duan et al., submitted) .
RPLs and Fusion assays. RPL lipid compositions, detailed methods for RPL preparation, and the in vitro fusion assay are described in the companion study (Duan et al., submitted) . In this 420 study additional SNARE topologies were tested, as described in the Results. The molar protein:phospholipid ratio for 4-SNARE liposomes was 1:1200, and 1:600 for Qabc and R SNARE RPLs. For certain experiments, as specified, reactions were set up with a non-standard order of reagent addition, and/or fusion was initiated by adding PEG, rather than by adding Sly1 or its mutants. 
